Read the full paper here (open access) Drug Science submits it’s finding concerning the UK Medical cannabis industry. In our recent peer-reviewed publication, Drug Science examines the current barriers to prescribing medical cannabis; ethical issues that arise from that process and we present our recommendations for best practice within this space. In the UK, medical  …

Drug Science stands by its e-cigarette analysis from 2014, any way of radically reducing the death toll from tobacco would be a worldwide public health triumph. e-cigarettes are not the solution to end the ever-increasing death toll caused by tobacco. However, they have proven to be an incredibly effective tool for tens of thousands of  …

Read the full paper here (open access) We present the preliminary data in the Bristol-Imperial MDMA-for-Alcoholism (BIMA) study, an ongoing open-label safety and tolerability proof of concept study exploring the potential role for 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in treating patients with alcohol use disorder (AUD). At this stage, eleven participants have completed the full 8-week MDMA-assisted  …

As summer approaches and with an increasing number of outdoor events in the calendar, the pop-up drug scene comes back into focus. As with previous years, MDMA (ecstasy), the most prominent drug at festivals and clubs, is likely to dominate again. Tragedy has struck down a number of young lives with MDMA related deaths increasing  …

An alarming rise in drug-related deaths at music festivals can be countered by testing illicit substances onsite, according to the first academic study of its kind [PDF download], which has triggered calls for similar services to be rolled out at all major events. Samples contained ketamine instead of cocaine, while a drug sold as MDMA  …

This blog discusss DrugScience's latest multi-criterion decision analysis of cannabis and alcohol regulation. Read the open access paper here. We’re all used to weighing up the benefits and pitfalls in our decision making. Is it worth the cost? Is it safe? Will I be able to get up in the morning? These are all simple  …

In collaboration with drug experts in Norway and the UK, multi-criteria decision analysis has been applied to evaluating drug policies for the first time - read the paper here. We have previously applied this technique to investigate harms of common recreational drugs in 2010, and nicotine-containing products in 2014. Drug policy, whether for legal or  …